Symmetry Partners’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-3,453
| Closed | -$319K | – | 234 |
|
|
2024
Q2 | $319K | Hold |
3,453
| – | – | 0.02% | 393 |
|
|
2024
Q1 | $330K | Hold |
3,453
| – | – | 0.03% | 393 |
|
|
2023
Q4 | $265K | Hold |
3,453
| – | – | 0.01% | 430 |
|
|
2023
Q3 | $239K | Sell |
3,453
-582
| -14% | -$40.3K | 0.01% | 475 |
|
|
2023
Q2 | $381K | Hold |
4,035
| – | – | 0.02% | 408 |
|
|
2023
Q1 | $334K | Sell |
4,035
-2,592
| -39% | -$215K | 0.02% | 430 |
|
|
2022
Q4 | $494K | Sell |
6,627
-783
| -11% | -$58.4K | 0.03% | 334 |
|
|
2022
Q3 | $612K | Hold |
7,410
| – | – | 0.04% | 256 |
|
|
2022
Q2 | $705K | Hold |
7,410
| – | – | 0.05% | 234 |
|
|
2022
Q1 | $872K | Hold |
7,410
| – | – | 0.05% | 221 |
|
|
2021
Q4 | $960K | Hold |
7,410
| – | – | 0.06% | 222 |
|
|
2021
Q3 | $806K | Hold |
7,410
| – | – | 0.05% | 273 |
|
|
2021
Q2 | $767K | Sell |
7,410
-516
| -7% | -$53.4K | 0.05% | 291 |
|
|
2021
Q1 | $663K | Sell |
7,926
-216
| -3% | -$18.1K | 0.05% | 313 |
|
|
2020
Q4 | $743K | Sell |
8,142
-1,041
| -11% | -$95K | 0.06% | 255 |
|
|
2020
Q3 | $733K | Buy |
9,183
+1,822
| +25% | +$145K | 0.06% | 223 |
|
|
2020
Q2 | $509K | Sell |
7,361
-2,914
| -28% | -$201K | 0.06% | 147 |
|
|
2020
Q1 | $646K | Buy |
10,275
+648
| +7% | +$40.7K | 0.14% | 74 |
|
|
2019
Q4 | $749K | Buy |
9,627
+5,052
| +110% | +$393K | 0.15% | 87 |
|
|
2019
Q3 | $335K | Buy |
4,575
+684
| +18% | +$50.1K | 0.07% | 236 |
|
|
2019
Q2 | $240K | Sell |
3,891
-2,667
| -41% | -$165K | 0.05% | 283 |
|
|
2019
Q1 | $418K | Buy |
6,558
+2,529
| +63% | +$161K | 0.07% | 181 |
|
|
2018
Q4 | $206K | Buy |
+4,029
| New | +$206K | 0.05% | 235 |
|